2023 Target Price: 88$/share, by applying a 12x forward P/E multiple to 2023 estimated earnings of $8.83/share.
Embedded Files
Associated Articles:
The Stock Of This Healthcare and Staples Company CVS Is Currently Undervalued. We See 15% Upside Ahead.
Monday, 13 Mar 2023 11:30 AM
Page updated
Google Sites
Report abuse